论文部分内容阅读
我院自1997年以来静滴头孢哌酮钠（先锋必素）治疗新生儿感染性疾病收到了较 好疗效,2年间共治疗120例,其中10例出现 出血症状,发生率8.33％。现报告如下。 临床资料 本组10例新生儿中男6例、 女4例,日龄最小7天,最大21天。10例均在 产科生后立即常规注射过一次Vit K1 2 mg。 入院诊断:新生儿肺炎5例,新生儿脐炎3例, 新生儿上呼吸道感染2例。此10例患儿入院 时,出、凝血时间、血小板计数、凝血酶原时间 以及三大常规、血细菌培养、C反应蛋白检查 均正常,且临床上可排除严重感染性休克、弥
In our hospital since 1997, intravenous cefoperazone sodium (Pioneer) for the treatment of neonatal infectious diseases received a good effect, a total of 120 cases were treated in 2 years, of which 10 cases showed bleeding symptoms, the incidence rate of 8.33%. The report is as follows. Clinical data of 10 newborns in this group, 6 males and 4 females, the minimum age of 7 days, maximum 21 days. All 10 patients were routinely injected with Vit K1 2 mg immediately after the obstetrics. Admission diagnosis: neonatal pneumonia in 5 cases, 3 cases of neonatal omphalitis, neonatal upper respiratory tract infection in 2 cases. The 10 cases of children admitted to hospital, clotting time, platelet count, prothrombin time and the three routine, blood culture, C-reactive protein were normal, and can be clinically excluded from severe septic shock, Mi